We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Molecular Assay Assesses Asymptomatic Malaria

By LabMedica International staff writers
Posted on 03 Jan 2012
In malaria endemic areas, molecular techniques allow a more accurate assessment of the asymptomatic parasite burden in the local population. More...


In these areas, individuals frequently have no symptoms and go undetected by conventional microscopy or newer, rapid diagnostic tests (RDTs), but the parasites can be detected by polymerase chain reaction (PCR).

A study was carried out under the auspices of the London School of Hygiene and Tropical Medicine (UK), in a region of northeastern Tanzania to determine the relative prevalence of submicroscopic level parasite carriage and clonal complexity of infections over a range of endemicities. This study used 1,121 blood samples collected from a previously conducted cross-sectional malariometric survey during the short rainy season in 2001 from 13 villages at three different altitudes. Samples were analyzed by PCR for carriage of parasites and multiplicity of infection. The data was compared with other measures of transmission intensity collected from the same area. The PCR was carried out in a tetrad thermo-cycler (PTC-0240, The DNA engine Tetrad2 Thermal Cycler, Bio-Rad; Hercules, CA, USA), followed by gel electrophoresis to assign individuals as either parasite positive or negative.

A 2.5-fold difference was observed when parasite prevalence was compared between PCR at 34.7% and 13.6% by microscopy. This fold difference was relatively consistent at the different altitude bands despite a marked decrease in parasite prevalence with altitude. Multiplicity of infection (MOI) ranged from 1.2 to 3.7 and was positively associated with parasite prevalence assessed by both PCR and microscopy. There was no association of MOI and age. The difference between parasite prevalence by PCR was 3.2 in individuals aged between 15 and 45 years compared with 2.5 in those aged from one to five years.

The authors concluded that a large number of individuals carried submicroscopic parasites in a malaria endemic area of Tanzania and they are a potential reservoir of infection in the population. These infections are important as potential contributors to the infectious reservoir of parasites and need to be identified by control programs especially in this era where malaria elimination is a focus. High throughput standardized PCR approaches are needed to identify individuals who are malaria carriers. The study was published online on December 16 2011 in the Malaria Journal.

Related Links:

London School of Hygiene and Tropical Medicine
Bio-Rad



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.